Thadani U, Chiong M A, Parker J O
Cardiology. 1979;64(6):333-49. doi: 10.1159/000170632.
The effects of glucose-insulin-potassium (GIK) and placebo normal saline (S) infusion on treadmill-walking time to angina, ST depression, heart rate (HR), systolic blood pressure (SBP), rate pressure product (RPP), blood glucose (G), lactate (L) and free fatty acids (FFA) were studied in 14 non diabetic patients with exertional angina. For the whole group, the post-GIK walking time to angina (393 +/- 33 sec, mean +/- SEM) was greater than the values during control GIK (319 +/- 20 sec, p less than 0.02) and post-S infusion (334 +/- sec, p less than 0.05), but circulatory and ST responses were similar in post-GIK and post-S studies. 7 of the 14 patients experienced significantly greater improvement in exercise tolerance following GIK (467 +/- 39 sec) in comparison to control GIK (313 +/- 29 sec, p less than 0.001) and post-S infusion (334 +/- 32 sec, p less than 0.005) and exercised to a higher HR, SBP and RPP after GIK than after S infusion. At the onset of angina these patients had similar ST-segment depression before and after GIK but when ST segments were assessed after GIK at the same exercise duration when angina had occurred during the control and post-S studies, there was significantly less ST depression (p less than 0.01). Of the remaining 7 patients exercise tolerance following GIK deteriorated in 3, remained unchanged in 2 and increased by 12 and 48 sec in 2 patients in comparison to post-S values. Comparison of post-GUK and post-S values for G, L and FFA for the whole group showed significantly lower resting values of FFA and post-exercise values of G following GIK infusion. The differences in clinical and circulatory responses between patients who improved and those who did not improve following GIK were not related to the angiographically determined severity of coronary artery disease or to GIK-induced metabolic changes. Results suggest that some patients with angina pectoris do benefit from GIK infusion but the response in a given patient to this therapeutic modality is unpredictable.
在14例非糖尿病性劳力性心绞痛患者中,研究了葡萄糖-胰岛素-钾(GIK)和安慰剂生理盐水(S)输注对运动平板试验中出现心绞痛的行走时间、ST段压低、心率(HR)、收缩压(SBP)、心率血压乘积(RPP)、血糖(G)、乳酸(L)和游离脂肪酸(FFA)的影响。对于整个研究组,输注GIK后出现心绞痛的行走时间(393±33秒,均值±标准误)长于输注GIK前对照期(319±20秒,p<0.02)及输注S后(334±秒,p<0.05),但输注GIK后与输注S后的循环及ST段反应相似。14例患者中有7例在输注GIK后运动耐量显著改善(467±39秒),相比输注GIK前对照期(313±29秒,p<0.001)及输注S后(334±32秒,p<0.005),且输注GIK后比输注S后运动至更高的心率、收缩压和心率血压乘积。在出现心绞痛时,这些患者在输注GIK前后ST段压低相似,但当在对照期和输注S后研究中出现心绞痛时,在相同运动持续时间下评估输注GIK后的ST段时,ST段压低显著减轻(p<0.01)。其余7例患者中,3例输注GIK后的运动耐量恶化,2例不变,2例相比输注S后分别增加了12秒和48秒。对整个研究组输注GIK和输注S后的血糖、乳酸和游离脂肪酸值进行比较,结果显示输注GIK后游离脂肪酸的静息值及运动后血糖值显著降低。输注GIK后改善和未改善的患者在临床和循环反应上的差异与血管造影确定的冠状动脉疾病严重程度或GIK诱导的代谢变化无关。结果表明,部分心绞痛患者确实从输注GIK中获益,但特定患者对这种治疗方式的反应不可预测。